mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |